William T. Nash

William T. Nash

Auto-generated profile, based on publicly available information

William T. Nash

University of Virginia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2014 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
WNWilliam T. Nash
William T. Nash
JTJeffrey Teoh
Jeffrey Teoh
HWHairong Wei
Hairong Wei
AGAwndre Gamache
Awndre Gamache
MBMichael G. Brown
Michael G. Brown
Natural killer cells (NK) provide essential protection against viral infections. One of the defining features of this lymphocyte population is the expression of a wide array of variable cell surface stimulatory and inhibitory NK receptors (sNKR and iNKR respectively). The iNKR are particularly important in terms of NK cell education. As receptors specific for MHC class I (MHC I) molecules, they are responsible for self-tolerance and adjusting NK cell reactivity based the expression level of self-MHC I. The end result of this education is two-fold: 1) inhibitory signaling tunes the functional capacity of the NK cell, endowing greater potency with greater education, and 2) education on self allows the NK cell to detect aberrations in MHC I expression, a common occurrence during many viral infections. Many studies have indicated an important role for iNKR and MHC I in disease, making these receptors attractive targets for manipulating NK cell reactivity in the clinic. A greater understanding of iNKR and their ability to regulate NK cells will provide a basis for future attempts at translating their potential utility into benefits for human health.

1 November 2013 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
JPJessica Prince
Jessica Prince
ALAlyssa Lundgren
Alyssa Lundgren
MSMichael D. Stadnisky
Michael D. Stadnisky
WNWilliam T. Nash
William T. Nash
ABAmira Beeber
Amira Beeber
MBMichael G. Brown
Michael G. Brown
MHC class I Dk and Ly49G2 (G2) inhibitory receptor–expressing NK cells are essential to murine CMV (MCMV) resistance in MA/My mice. Without Dk, G2+ NK cells in C57L mice fail to protect against MCMV infection. As a cognate ligand of G2, Dk licenses G2+ NK cells for effector activity. These data suggested that Dk-licensed G2+ NK cells might recognize and control MCMV infection. However, a role for licensed NK cells in viral immunity is uncertain. We combined classical genetics with flow cytometry to visualize the host response to MCMV. Immune cells collected from individuals of a diverse cohort of MA/My × C57L offspring segregating Dk were examined before infection and postinfection, including Ly49+ NK subsets, receptor expression features, and other phenotypic traits. To identify critical NK cell features, automated analysis of 110 traits was performed in R using the Pearson correlation, followed with a Bonferroni correction for multiple tests. Hierarchical clustering of trait associations and principal component analyses were used to discern shared immune response and genetic relationships. The results demonstrate that G2 expression on naive blood NK cells was predictive of MCMV resistance. However, rapid G2+ NK cell expansion following viral exposure occurred selectively in Dk offspring; this response was more highly correlated with MCMV control than all other immune cell features. We infer that Dk-licensed G2+ NK cells efficiently detected missing-self MHC cues on viral targets, which elicited cellular expansion and target cell killing. Therefore, MHC polymorphism regulates licensing and detection of viral targets by distinct subsets of NK cells required in innate viral control.

3 September 2014 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
HWHairong Wei
Hairong Wei
WNWilliam T. Nash
William T. Nash
AMAndrew P. Makrigiannis
Andrew P. Makrigiannis
MBMichael G. Brown
Michael G. Brown
Ly49G2 (G2+) NK cells mediate murine (M)CMV resistance in MHC Dk‐expressing mice. Bone marrow transplantation (BMT) studies revealed that G2+ NK cell‐mediated MCMV resistance requires Dk in both hematopoietic and nonhematopoietic cells. As a Ly49G2 ligand, Dk in both cell lineages may contribute to lysis of virus‐infected cells. Alternatively, cellular differences in self‐MHC Dk may have affected NK‐cell education, and consequently NK cell‐mediated viral clearance. We investigated the Dk‐licensing effect on BM‐derived NK cells in BMT recipients by analyzing cytokines, cytotoxicity and MCMV resistance. In BMT recipients with lineage‐restricted Dk, G2+ NK‐cell reactivity and cytotoxicity was diminished in comparison to BMT recipients with self‐MHC in all cells. Reduced G2+ NK‐mediated MCMV resistance in BMT recipients with lineage‐restricted self‐MHC indicates that licensing of G2+ NK cells is related to NK‐cell reactivity and viral control. Titrating donor BM with self‐MHC‐bearing hematopoietic cells, as well as adoptive transfer of mature G2+ NK cells into BMT recipients with self‐MHC in non‐hematopoietic cells only, enhanced NK‐cell licensing and rescued MCMV resistance. This disparate self‐MHC NK‐cell education model would suggest that inadequately licensed NK cells corresponded to inefficient viral sensing and clearance.

30 November 2018 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
PDF file
MBMichael G. Brown
Michael G. Brown
AGAwndre Gamache
Awndre Gamache
WNWilliam T. Nash
William T. Nash
JCJohn Cronk
John Cronk

4 February 2016 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
AGAlyssa Lundgren Gillespie
Alyssa Lundgren Gillespie
JTJeffrey Teoh
Jeffrey Teoh
HLHeather Lee
Heather Lee
JPJessica Prince
Jessica Prince
MSMichael D. Stadnisky
Michael D. Stadnisky
MBMichael G. Brown
Michael G. Brown
The MHC class I Dk molecule supplies vital host resistance during murine cytomegalovirus (MCMV) infection. Natural killer (NK) cells expressing the Ly49G2 inhibitory receptor, which specifically binds Dk, are required to control viral spread. The extent of Dk-dependent host resistance, however, differs significantly amongst related strains of mice, C57L and MA/My. As a result, we predicted that relatively small-effect modifier genetic loci might together shape immune cell features, NK cell reactivity, and the host immune response to MCMV. A robust Dk-dependent genetic effect, however, has so far hindered attempts to identify additional host resistance factors. Thus, we applied genomic mapping strategies and multicolor flow cytometric analysis of immune cells in naive and virus-infected hosts to identify genetic modifiers of the host immune response to MCMV. We discovered and validated many quantitative trait loci (QTL); these were mapped to at least 19 positions on 16 chromosomes. Intriguingly, one newly discovered non-MHC locus (Cmv5) controlled splenic NK cell accrual, secondary lymphoid organ structure, and lymphoid follicle development during MCMV infection. We infer that Cmv5 aids host resistance to MCMV infection by expanding NK cells needed to preserve and protect essential tissue structural elements, to enhance lymphoid remodeling and to increase viral clearance in spleen. Uncovering the genetic basis of resistance to viral infection and disease is critical to learning about how immune defenses might be adjusted, how to design better vaccines, and how to elicit effectual immune protection in human populations. Prior studies have shown that both MHC and non-MHC genes support host defenses, or endow specialized immune cells with efficient sensing or responsiveness to infection. Many additional resistance genes remain to be identified, including difficult to detect smaller-effect alleles, which might add to or interact with other genetic factors. Our grasp of the complex interaction involving these genetic elements is thus inadequate. We combined genomic and multiparameter phenotypic analyses to map and identify host genes that control immune cells or sensitivity to viral infection. We reasoned that some might also affect viral clearance. Thus we enumerated a range of immune cell traits in mice before and after infection, which permitted genomic analysis of viral immunity, and mapping of genetic modifiers for each trait. Our study demonstrates that distinct loci collectively regulate both NK cells and host resistance, which provides a framework to understand the genetic interactions, and a variety of potential novel targets to adjust NK cell functionality and host resistance to infection.

1 June 2025 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
NPNabin Poudel
Nabin Poudel
SZShuqiu Zheng
Shuqiu Zheng
NSNataliya Skrypnyk
Nataliya Skrypnyk
SSSun-Sang J. Sung
Sun-Sang J. Sung
EGEibhlin Goggins
Eibhlin Goggins
MOMark D. Okusa
Mark D. Okusa
Despite the huge medical, economical, and quality of life burden that AKI poses to patients, there are no Food and Drug Administration (FDA)-approved therapeutic or pharmaceutical interventions for AKI. Pannexin 1 (Panx1), which is upregulated in patients with AKI as well as in animals that develop experimental AKI, plays a crucial role in mediating both inflammation and cell death during AKI. Our findings suggest clinical interventions with molecules that inhibit Panx1 channel activity could improve outcomes in AKI patients.